We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-2.48%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$14.7M
(-8.3%)
Cap. Flow
-$3.99M
Cap. Flow
% of AUM
-2.47%
Top 10 Holdings %
Top 10 Hldgs %
35.84%
Holding
111
New
5
Increased
11
Reduced
28
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMED
Sharps Compliance Corp
SMED
|
+$1.1M |
| 2 |
Elutia
ELUT
|
+$604K |
| 3 |
Inuvo
INUV
|
+$535K |
| 4 |
Ooma
OOMA
|
+$430K |
| 5 |
QTEX
QTREX Quantum
QTEX
|
+$338K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$3.21M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$1.05M |
| 3 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$796K |
| 4 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
+$635K |
| 5 |
IIN
IntriCon Corporation
IIN
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.55% |
| 2 | Technology | 15.76% |
| 3 | Communication Services | 6.55% |
| 4 | Industrials | 5.57% |
| 5 | Consumer Staples | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphatec Holdings
ATEC
$1.57B
| $2.09M | 1.3% |
171,600
-5,150
| -3% | -$71.8K |
|
|
BIOL
27
DELISTED
Biolase, Inc.
BIOL
| $2M | 1.24% |
1,254
+5
| +0.4% | +$8.16K |
|
|
ATRS
28
DELISTED
Antares Pharma, Inc.
ATRS
| $1.97M | 1.22% |
540,783
-1,000
| -0.2% | -$4.04K |
|
|
RYM
29
RYTHM Inc
RYM
$45M
| $1.95M | 1.21% |
35
| – | – |
|
30
Perion Network
PERI
$388M
| $1.94M | 1.2% |
111,851
| – | – |
|
|
PFIE
31
DELISTED
Profire Energy, Inc
PFIE
| $1.8M | 1.12% |
1,568,765
-3,495
| -0.2% | -$3.8K |
|
|
ASPU
32
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.79M | 1.11% |
321,250
| – | – |
|
33
Target
TGT
$67.2B
| $1.78M | 1.1% |
7,779
-50
| -0.6% | -$12.5K |
|
|
AKTS
34
DELISTED
Akoustis Technologies Inc
AKTS
| $1.77M | 1.09% |
182,200
| – | – |
|
|
AVGR
35
DELISTED
Avinger, Inc. Common Stock
AVGR
| $1.76M | 1.09% |
7,866
-22
| -0.3% | -$6.07K |
|
|
XLNX
36
DELISTED
Xilinx Inc
XLNX
| $1.63M | 1.01% |
10,795
| – | – |
|
|
ZIXI
37
DELISTED
Zix Corporation
ZIXI
| $1.63M | 1.01% |
230,175
| – | – |
|
|
38
Elutia
ELUT
$38.3M
| $1.59M | 0.98% |
228,425
+74,000
| +48% | +$604K |
|
39
Achieve Life Sciences
ACHV
$649M
| $1.44M | 0.89% |
169,600
-2,500
| -1% | -$19.6K |
|
40
AbbVie
ABBV
$432B
| $1.33M | 0.82% |
12,313
| – | – |
|
41
Rockwell Medical
RMTI
$28.5M
| $1.31M | 0.81% |
19,988
-5,236
| -21% | -$397K |
|
42
QuickLogic
QUIK
$253M
| $1.3M | 0.8% |
241,785
| – | – |
|
43
3M
MMM
$91.8B
| $1.15M | 0.71% |
7,841
| – | – |
|
44
Gilead Sciences
GILD
$163B
| $1.14M | 0.71% |
16,300
+900
| +6% | +$63.2K |
|
|
PDCO
45
DELISTED
Patterson Companies, Inc.
PDCO
| $1.11M | 0.69% |
36,950
| – | – |
|
46
AT&T
T
$159B
| $1.09M | 0.67% |
53,429
-827
| -2% | -$17.4K |
|
|
SRXH
47
SRX Global
SRXH
$28.1M
| $1.08M | 0.67% |
149
-4
| -3% | -$29.9K |
|
48
Perspective Therapeutics
CATX
$349M
| $980K | 0.61% |
155,300
-10,100
| -6% | -$68.8K |
|
|
SMED
49
DELISTED
Sharps Compliance Corp
SMED
| $976K | 0.6% |
+118,000
| New | +$1.1M |
|
50
Bristol-Myers Squibb
BMY
$132B
| $973K | 0.6% |
16,450
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Perkins Capital Management held 111 positions worth $162M, down 8.3% from $176M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management's Q3 2021 filing shows 5 new, 11 increased, 28 reduced and 5 closed positions. Its largest new stake was Sharps Compliance Corp: 118,000 shares worth $976K. The largest sale was CareDx, an estimated $3.21M.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q3 2021 buy was Sharps Compliance Corp: 118,000 shares worth $976K.
- Perkins Capital Management added most to Elutia in Q3 2021, an estimated $604K increase.
- Perkins Capital Management's biggest Q3 2021 reduction was CareDx, cutting an estimated $3.21M.
- Perkins Capital Management fully exited Chembio diagnostics, Inc. in Q3 2021, selling an estimated $796K.
- Perkins Capital Management's ten largest holdings make up 36% of its $162M portfolio in Q3 2021.
- Perkins Capital Management opened 5 new positions and closed 5 in Q3 2021.
- Perkins Capital Management's portfolio value fell 8.3% quarter-over-quarter to $162M.
Based on Perkins Capital Management's 13F filing for Q3 2021, filed 25 Oct 2021.